The DOI matches its Crossref record; 262 of the 262 references it cites were found in a registry or an index.
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
Open accessAbstract
BACKGROUND: Due to the high prevalence of overweight and obesity there is a need to identify cost-effective approaches for weight loss in primary care and community settings. OBJECTIVE: We evaluated the cost effectiveness of two weight loss programmes of 1-year duration, either standard care (SC) as defined by national guidelines, or a commercial provider (Weight Watchers) (CP). DESIGN: This analysis was based on a randomised controlled trial of 772 adults (87% female; age 47.4±12.9 years; body mass index 31.4±2.6 kg m(-2)) recruited by health professionals in primary care in Australia, United Kingdom and Germany. Both a health sector and societal perspective were adopted to calculate the cost per kilogram of weight loss and the ICER, expressed as the cost per quality adjusted life year (QALY). RESULTS: The cost per kilogram of weight loss was USD122, 90 and 180 for the CP in Australia, the United Kingdom and Germany, respectively. For SC the cost was USD138, 151 and 133, respectively. From a health-sector perspective, the ICER for the CP relative to SC was USD18 266, 12 100 and 40 933 for Australia, the United Kingdom and Germany, respectively. Corresponding societal ICER figures were USD31,663, 24,996 and 51,571. CONCLUSION: The CP was a cost-effective approach from a health funder and societal perspective. Despite participants in the CP group attending two to three times more meetings than the SC group, the CP was still cost effective even including these added patient travel costs. This study indicates that it is cost effective for general practitioners (GPs) to refer overweight and obese patients to a CP, which may be better value than expending public funds on GP visits to manage this problem.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Advice on low-fat diets for obesity
Pirozzo, S., Summerbell, C., Cameron, C. M., & Glasziou, P. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003640 · Cited by 92
RetractedReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
(2000) · PubMed · Cited by 13,173
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
‘Small Changes' to Diet and Physical Activity Behaviors for Weight Management
Hills, A. P., Byrne, N. M., Lindstrom, R., & Hill, J. O. (2013) · Obesity Facts · doi:10.1159/000345030 · Cited by 9,493
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Identification and Importance of Brown Adipose Tissue in Adult Humans
Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y.-H., Doria, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810780 · Cited by 4,399
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354
Cold-Activated Brown Adipose Tissue in Healthy Men
van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M. A. F. L., Kemerink, G. J., Bouvy, N. D., Schrauwen, P., & Teule, G. J. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808718 · Cited by 3,452
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Tilg, H., & Moschen, A. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1937 · Cited by 3,188
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Functional Brown Adipose Tissue in Healthy Adults
Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E., & Weigle, D. S. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1714 · Cited by 2,940
Fox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C.-Y., Vasan, R. S., Murabito, J. M., Meigs, J. B., Cupples, L. A., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.675355 · Cited by 2,882
Long-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572
Central nervous system control of food intake and body weight
Morton, G. J., Cummings, D. E., Baskin, D. G., Barsh, G. S., & Schwartz, M. W. (2006) · Nature · doi:10.1038/nature05026 · Cited by 2,503
Bioelectrical impedance analysis—part II: utilization in clinical practice
Kyle, U. G., Bosaeus, I., De Lorenzo, A. D., Deurenberg, P., Elia, M., Manuel Gómez, J., Lilienthal Heitmann, B., Kent-Smith, L., Melchior, J.-C., Pirlich, M., et al. (2004) · Clinical Nutrition · doi:10.1016/j.clnu.2004.09.012 · Cited by 2,350
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.
Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2391 · Cited by 2,292
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
Adams, K. F., Schatzkin, A., Harris, T. B., Kipnis, V., Mouw, T., Ballard-Barbash, R., Hollenbeck, A., & Leitzmann, M. F. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055643 · Cited by 2,116
XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.155 · Cited by 1,915
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.001 · Cited by 1,885
Sjöström, L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12012 · Cited by 1,835
Obesity, Inflammation, and Insulin Resistance
Shoelson, S. E., Herrero, L., & Naaz, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.059 · Cited by 1,806
Lindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., et al. (2007) · Nature · doi:10.1038/nature06261 · Cited by 1,707
Relationship between stress, eating behavior, and obesity
Torres, S. J., & Nowson, C. A. (2007) · Nutrition · doi:10.1016/j.nut.2007.08.008 · Cited by 1,622
Inhibition of Food Intake in Obese Subjects by Peptide YY 3–36
Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030204 · Cited by 1,604
Laupacis, A., Feeny, D. H., Detsky, A. S., & Tugwell, P. (1992) · Europe PMC (PubMed Central) · Cited by 1,581
Meta-Analysis: Surgical Treatment of Obesity
Maggard, M. A., Shugarman, L. R., Suttorp, M., Maglione, M., Sugerman, H. J., Livingston, E. H., Nguyen, N. T., Li, Z., Mojica, W. A., Hilton, L., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00013 · Cited by 1,567
Consensus development conference on antipsychotic drugs and obesity and diabetes
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity (2004) · Diabetes Care · doi:10.2337/diacare.27.2.596 · Cited by 1,554
Cause-Specific Excess Deaths Associated With Underweight, Overweight, and Obesity
Flegal, K. M., Graubard, B. I., Williamson, D. F., & Gail, M. H. (2007) · JAMA · doi:10.1001/jama.298.17.2028 · Cited by 1,542
Wang, Y., Beydoun, M. A., Liang, L., Caballero, B., & Kumanyika, S. K. (2008) · Obesity · doi:10.1038/oby.2008.351 · Cited by 1,518
Long-term weight-loss maintenance: a meta-analysis of US studies
Anderson, J. W., Konz, E. C., Frederich, R. C., & Wood, C. L. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.5.579 · Cited by 1,351
AMPK and PPARδ Agonists Are Exercise Mimetics
Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y.-X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.051 · Cited by 1,222
Gastrointestinal regulation of food intake
Cummings, D. E., & Overduin, J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30227 · Cited by 1,216
The Role of Cost-effectiveness Analysis in Health and Medicine
Russell, L. B. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540140060028 · Cited by 1,167
Astrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163
Lau, D. C. W., Douketis, J. D., Morrison, K. M., Hramiak, I. M., Sharma, A. M., Ur, E., & Panel, F. M. O. T. O. C. C. P. G. E. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.061409 · Cited by 1,154
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Christensen, R., Kristensen, P. K., Bartels, E. M., Bliddal, H., & Astrup, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61721-8 · Cited by 1,097
Nutrient sensing and inflammation in metabolic diseases
Hotamisligil, G. S., & Erbay, E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2449 · Cited by 1,040
Nordmann, A. J., Nordmann, A., Briel, M., Keller, U., Yancy, W. S., Brehm, B. J., & Bucher, H. C. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.3.285 · Cited by 973
(1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.17.1855 · Cited by 936
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1
Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088682 · Cited by 915
The tempted brain eats: Pleasure and desire circuits in obesity and eating disorders
Berridge, K. C., Ho, C.-Y., Richard, J. M., & DiFeliceantonio, A. G. (2010) · Brain Research · doi:10.1016/j.brainres.2010.04.003 · Cited by 873
Pancreatic lipase inhibitors from natural sources: Unexplored potential
Birari, R. B., & Bhutani, K. K. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.024 · Cited by 871
Saris, W. H. M., Blair, S. N., Van Baak, M. A., Eaton, S. B., Davies, P. S. W., Di Pietro, L., Fogelholm, M., Rissanen, A., Schoeller, D., Swinburn, B., et al. (2003) · Obesity Reviews · doi:10.1046/j.1467-789x.2003.00101.x · Cited by 865
Adipose tissue mass can be regulated through the vasculature
Rupnick, M. A., Panigrahy, D., Zhang, C.-Y., Dallabrida, S. M., Lowell, B. B., Langer, R., & Folkman, M. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162349799 · Cited by 845
Effect of sibutramine on weight maintenance after weight loss: a randomised trial
James, W. P. T., Astrup, A., Finer, N., Hilsted, J., Kopelman, P., Rössner, S., Saris, W. H. M., & Gaal, L. F. V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03491-7 · Cited by 817
Systematic Review: An Evaluation of Major Commercial Weight Loss Programs in the United States
Tsai, A. G., & Wadden, T. A. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00012 · Cited by 815
The epidemiology of obesity: the size of the problem
James, W. P. T. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01922.x · Cited by 786
Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery
on behalf of International Federation for the Surgery of Obesity and Metabolic Disorders—European Chapter (IFSO-EC) and European Association for the Study of Obesity (EASO), Fried, M., Yumuk, V., Oppert, J. M., Scopinaro, N., Torres, A., Weiner, R., Yashkov, Y., & Frühbeck, G. (2014) · Obesity Surgery · doi:10.1007/s11695-013-1079-8 · Cited by 753
Drug treatments for obesity: orlistat, sibutramine, and rimonabant
Padwal, R. S., & Majumdar, S. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60033-6 · Cited by 753
Angiogenesis modulates adipogenesis and obesity
Cao, Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32239 · Cited by 736
Feige, J. N., Lagouge, M., Canto, C., Strehle, A., Houten, S. M., Milne, J. C., Lambert, P. D., Mataki, C., Elliott, P. J., & Auwerx, J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.017 · Cited by 719
Janssen, I., Heymsfield, S. B., Allison, D. B., Kotler, D. P., & Ross, R. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.4.683 · Cited by 714
Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial
Ross, R., Janssen, I., Dawson, J., Kungl, A., Kuk, J. L., Wong, S. L., Nguyen‐Duy, T., Lee, S., Kilpatrick, K., & Hudson, R. (2004) · Obesity Research · doi:10.1038/oby.2004.95 · Cited by 696
Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality
Romero-Corral, A., Somers, V. K., Sierra-Johnson, J., Korenfeld, Y., Boarin, S., Korinek, J., Jensen, M. D., Parati, G., & Lopez-Jimenez, F. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp487 · Cited by 688
Zhu, S., Wang, Z., Heshka, S., Heo, M., Faith, M. S., & Heymsfield, S. B. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.4.743 · Cited by 682
Inequalities in non-communicable diseases and effective responses
Di Cesare, M., Khang, Y.-H., Asaria, P., Blakely, T., Cowan, M. J., Farzadfar, F., Guerrero, R., Ikeda, N., Kyobutungi, C., Msyamboza, K. P., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61851-0 · Cited by 678
Prospective association between obesity and depression: evidence from the Alameda County Study
Roberts, R. E., Deleger, S., Strawbridge, W. J., & Kaplan, G. A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802204 · Cited by 673
Slentz, C. A., Duscha, B. D., Johnson, J. L., Ketchum, K., Aiken, L. B., Samsa, G. P., Houmard, J. A., Bales, C. W., & Kraus, W. E. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.1.31 · Cited by 656
Overton, H. A., Babbs, A. J., Doel, S. M., Fyfe, M. C. T., Gardner, L. S., Griffin, G., Jackson, H. C., Procter, M. J., Rasamison, C. M., Tang-Christensen, M., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.004 · Cited by 655
Neuroendocrine control of food intake
Valassi, E., Scacchi, M., & Cavagnini, F. (2008) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.06.004 · Cited by 645
Visceral Fat Is an Independent Predictor of All‐cause Mortality in Men
Kuk, J. L., Katzmarzyk, P. T., Nichaman, M. Z., Church, T. S., Blair, S. N., & Ross, R. (2006) · Obesity · doi:10.1038/oby.2006.43 · Cited by 642
Development of a brief measure to assess quality of life in obesity
Kolotkin, R. L., Crosby, R. D., Kosloski, K. D., & Williams, G. R. (2001) · Obesity Research · doi:10.1038/oby.2001.13 · Cited by 641
Johnson, N. A., Sachinwalla, T., Walton, D. W., Smith, K., Armstrong, A., Thompson, M. W., & George, J. (2009) · Hepatology · doi:10.1002/hep.23129 · Cited by 631
Reversal of obesity by targeted ablation of adipose tissue
Kolonin, M. G., Saha, P. K., Chan, L., Pasqualini, R., & Arap, W. (2004) · Nature Medicine · doi:10.1038/nm1048 · Cited by 601
Cellular bioenergetics as a target for obesity therapy
Tseng, Y.-H., Cypess, A. M., & Kahn, C. R. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3138 · Cited by 591
Farooqi, I. S., & O’Rahilly, S. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0040 · Cited by 583
Weight management using a meal replacement strategy: meta and pooling analysis from six studies.
Heymsfield, S. B., van Mierlo, C. A. J., van der Knaap, H. C. M., Heo, M., & Frier, H. I. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802258 · Cited by 557
Yanovski, S. Z., & Yanovski, J. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra012586 · Cited by 544
Jakicic, J. M., Marcus, B. H., Gallagher, K. I., Napolitano, M., & Lang, W. (2003) · JAMA · doi:10.1001/jama.290.10.1323 · Cited by 519
Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review
Li, R., Zhang, P., Barker, L. E., Chowdhury, F. M., & Zhang, X. (2010) · Diabetes Care · doi:10.2337/dc10-0843 · Cited by 491
Astrup, A., Grunwald, G., Melanson, E., Saris, W., & Hill, J. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801453 · Cited by 468
Meta-analysis: The Effect of Dietary Counseling for Weight Loss
Dansinger, M. L., Tatsioni, A., Wong, J. B., Chung, M., & Balk, E. M. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-1-200707030-00007 · Cited by 467
Management of Obesity in Adults: European Clinical Practice Guidelines
Tsigos, C., Hainer, V., Basdevant, A., Finer, N., Fried, M., Mathus-Vliegen, E., Micic, D., Maislos, M., Roman, G., Schutz, Y., et al. (2008) · Obesity Facts · doi:10.1159/000126822 · Cited by 443
Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases
Cao, Y. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3055 · Cited by 442
Livesey, G., Taylor, R., Hulshof, T., & Howlett, J. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.258s · Cited by 439
Jebb, S. A., Ahern, A. L., Olson, A. D., Aston, L. M., Holzapfel, C., Stoll, J., Amann-Gassner, U., Simpson, A. E., Fuller, N. R., Pearson, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61344-5 · Cited by 422
Self-citationObesity surgery: Evidence-based guidelines of the European Association for Endoscopic Surgery (EAES)
Sauerland, S., Angrisani, L., Belachew, M., Chevallier, J. M., Favretti, F., Finer, N., Fingerhut, A., Garcia Caballero, M., Guisado Macias, J. A., Mittermair, R., et al. (2005) · Surgical Endoscopy · doi:10.1007/s00464-004-9194-1 · Cited by 420
Cannabinoids and the gut: New developments and emerging concepts
Izzo, A. A., & Sharkey, K. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.12.005 · Cited by 419
Physical activity considerations for the treatment and prevention of obesity
Jakicic, J. M., & Otto, A. D. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn.82.1.226s · Cited by 406
Lauffer, L. M., Iakoubov, R., & Brubaker, P. L. (2009) · Diabetes · doi:10.2337/db08-1237 · Cited by 399
Mela, D. J. (2006) · Appetite · doi:10.1016/j.appet.2006.02.006 · Cited by 384
Stress, Visceral Obesity, and Metabolic Complications
KYROU, I., CHROUSOS, G. P., & TSIGOS, C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.008 · Cited by 380
Low glycaemic index or low glycaemic load diets for overweight and obesity
Thomas, D., Elliott, E. J., & Baur, L. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005105.pub2 · Cited by 376
Stevens, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf114 · Cited by 369
Jolly, K., Lewis, A., Beach, J., Denley, J., Adab, P., Deeks, J. J., Daley, A., & Aveyard, P. (2011) · BMJ · doi:10.1136/bmj.d6500 · Cited by 359
The influence of physical activity on abdominal fat: a systematic review of the literature
Kay, S. J., & Fiatarone Singh, M. A. (2006) · Obesity Reviews · doi:10.1111/j.1467-789x.2006.00250.x · Cited by 358
Ayyad, C., & Andersen, T. (2000) · Obesity Reviews · doi:10.1046/j.1467-789x.2000.00019.x · Cited by 355
Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young Adults
Fleischman, A., Shoelson, S. E., Bernier, R., & Goldfine, A. B. (2008) · Diabetes Care · doi:10.2337/dc07-1338 · Cited by 352
Lee, S., Kuk, J. L., Davidson, L. E., Hudson, R., Kilpatrick, K., Graham, T. E., & Ross, R. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00053.2005 · Cited by 348
McMillan-Price, J., Petocz, P., Atkinson, F., O’Neill, K., Samman, S., Steinbeck, K., Caterson, I., & Brand-Miller, J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.14.1466 · Cited by 335
Self-citationPRECLINICAL STUDY: FULL ARTICLE: Ghrelin increases intake of rewarding food in rodents
Egecioglu, E., Jerlhag, E., Salomé, N., Skibicka, K. P., Haage, D., Bohlooly‐Y, M., Andersson, D., Bjursell, M., Perrissoud, D., Engel, J. A., et al. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00216.x · Cited by 332
Ravussin, E., Smith, S. R., Mitchell, J. A., Shringarpure, R., Shan, K., Maier, H., Koda, J. E., & Weyer, C. (2009) · Obesity · doi:10.1038/oby.2009.184 · Cited by 332
Cannabinoids, opioids and eating behavior: The molecular face of hedonism?
Cota, D., Tschöp, M. H., Horvath, T. L., & Levine, A. S. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.10.004 · Cited by 330
Signal transduction of the CB1 cannabinoid receptor
Turu, G., & Hunyady, L. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0190 · Cited by 325
Health‐Related Quality of Life Varies among Obese Subgroups
Kolotkin, R. L., Crosby, R. D., & Williams, G. R. (2002) · Obesity Research · doi:10.1038/oby.2002.102 · Cited by 317
Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery
Fried, M., Yumuk, V., Oppert, J.-M., Scopinaro, N., Torres, A. J., Weiner, R., Yashkov, Y., & Frühbeck, G. (2013) · Obesity Facts · doi:10.1159/000355480 · Cited by 316
Metabolism of adipose tissue in intraabdominal depots of nonobese men and women
Rebuffé-Scrive, M., Andersson, B., Olbe, L., & Björntorp, P. (1989) · Metabolism · doi:10.1016/0026-0495(89)90198-4 · Cited by 311
Bult, M. J. F., van Dalen, T., & Muller, A. F. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0145 · Cited by 301
The Relationship between Health‐Related Quality of Life and Weight Loss
Kolotkin, R. L., Crosby, R. D., Williams, G. R., Hartley, G. G., & Nicol, S. (2001) · Obesity Research · doi:10.1038/oby.2001.73 · Cited by 284
Zonisamide for Weight Loss in Obese Adults: A Randomized Controlled Trial
Gadde, K. M., Franciscy, D. M., Wagner, H. R., & Krishnan, K. R. R. (2003) · JAMA · doi:10.1001/jama.289.14.1820 · Cited by 276
GPR119, a novel G protein‐coupled receptor target for the treatment of type 2 diabetes and obesity
Overton, H. A., Fyfe, M. C. T., & Reynet, C. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707529 · Cited by 264
Frühbeck, G., Toplak, H., Woodward, E., Yumuk, V., Maislos, M., Oppert, J.-M., & for the Executive Committee of the European Association for the Study of Obesity (2013) · Obesity Facts · doi:10.1159/000350627 · Cited by 264
Binge eating disorder, weight control self-efficacy, and depression in overweight men and women
Linde, J. A., Jeffery, R. W., Levy, R. L., Sherwood, N. E., Utter, J., Pronk, N. P., & Boyle, R. G. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802570 · Cited by 263
Pellicciari, R., Gioiello, A., Macchiarulo, A., Thomas, C., Rosatelli, E., Natalini, B., Sardella, R., Pruzanski, M., Roda, A., Pastorini, E., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901390p · Cited by 260
Dwoskin, L. P., Rauhut, A. S., King‐Pospisil, K. A., & Bardo, M. T. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00178.x · Cited by 259
The MC4 receptor and control of appetite
Adan, R. A. H., Tiesjema, B., Hillebrand, J. J. G., la Fleur, S. E., Kas, M. J. H., & de Krom, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706929 · Cited by 259
The future of obesity reduction: beyond weight loss
Ross, R., & Bradshaw, A. J. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.78 · Cited by 258
Bessesen, D. H. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0520 · Cited by 257
Lantz, K. A., Hart, S. G. E., Planey, S. L., Roitman, M. F., Ruiz‐White, I. A., Wolfe, H. R., & McLane, M. P. (2010) · Obesity · doi:10.1038/oby.2009.444 · Cited by 232
Shi, Y., & Cheng, D. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90949.2008 · Cited by 232
Treatment Modalities of Obesity
Hainer, V., Toplak, H., & Mitrakou, A. (2008) · Diabetes Care · doi:10.2337/dc08-s265 · Cited by 231
Krauth, C., Hessel, F., Hansmeier, T., Wasem, J., Seitz, R., & Schweikert, B. (2005) · Das Gesundheitswesen · doi:10.1055/s-2005-858698 · Cited by 225
PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice
Banno, R., Zimmer, D., De Jonghe, B. C., Atienza, M., Rak, K., Yang, W., & Bence, K. K. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39620 · Cited by 214
Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes
Chapman, I., Parker, B., Doran, S., Feinle-Bisset, C., Wishart, J., Strobel, S., Wang, Y., Burns, C., Lush, C., Weyer, C., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1732-4 · Cited by 205
Vickers, S. P., Dourish, C. T., & Kennett, G. A. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00063-6 · Cited by 202
Endocannabinoids selectively enhance sweet taste
Yoshida, R., Ohkuri, T., Jyotaki, M., Yasuo, T., Horio, N., Yasumatsu, K., Sanematsu, K., Shigemura, N., Yamamoto, T., Margolskee, R. F., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912048107 · Cited by 200
BAT: a new target for human obesity?
Frühbeck, G., Becerril, S., Sáinz, N., Garrastachu, P., & García-Velloso, M. J. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.05.003 · Cited by 197
Sikorski, C., Luppa, M., Kaiser, M., Glaesmer, H., Schomerus, G., König, H.-H., & Riedel-Heller, S. G. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-661 · Cited by 195
Histamine H3 Receptor Antagonists: Preclinical Promise for Treating Obesity and Cognitive Disorders
Esbenshade, T. A. (2006) · Molecular Interventions · doi:10.1124/mi.6.2.5 · Cited by 194
Astrup, A., Madsbad, S., Breum, L., Jensen, T. J., Kroustrup, J. P., & Larsen, T. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61525-1 · Cited by 193
Lorcaserin (APD356), a Selective 5‐HT2CAgonist, Reduces Body Weight in Obese Men and Women
Smith, S. R., Prosser, W. A., Donahue, D. J., Morgan, M. E., Anderson, C. M., Shanahan, W. R., & APD356‐004 Study Group (2009) · Obesity · doi:10.1038/oby.2008.537 · Cited by 192
Inhibition of ghrelin O -acyltransferase (GOAT) by octanoylated pentapeptides
Yang, J., Zhao, T.-J., Goldstein, J. L., & Brown, M. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805353105 · Cited by 191
Young, R. L., Sutherland, K., Pezos, N., Brierley, S. M., Horowitz, M., Rayner, C. K., & Blackshaw, L. A. (2009) · Gut · doi:10.1136/gut.2008.148932 · Cited by 189
Heal, D. J., Smith, S. L., Fisas, A., Codony, X., & Buschmann, H. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.08.006 · Cited by 184
Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug
Idris, I., & Donnelly, R. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00982.x · Cited by 181
The histamine H3 receptor as a therapeutic drug target for CNS disorders
Gemkow, M. J., Davenport, A. J., Harich, S., Ellenbroek, B. A., Cesura, A., & Hallett, D. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.02.011 · Cited by 181
Chandra, R., & Liddle, R. A. (2007) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3280122850 · Cited by 181
Assessment of obesity and its clinical implications
Han, T. S., Sattar, N., & Lean, M. (2006) · BMJ · doi:10.1136/bmj.333.7570.695 · Cited by 180
Avenell, A., Brown, T. J., McGee, M. A., Campbell, M. K., Grant, A. M., Broom, J., Jung, R. T., & Smith, W. C. S. (2004) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2004.00531.x · Cited by 180
Larsen, T. M., Toubro, S., van Baak, M. A., Gottesdiener, K. M., Larson, P., Saris, W. H., & Astrup, A. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.4.780 · Cited by 179
Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review
Leslie, W. S., Hankey, C. R., & Lean, M. E. J. (2007) · QJM · doi:10.1093/qjmed/hcm044 · Cited by 173
Interdisciplinary European Guidelines on Surgery of Severe Obesity
Fried, M., Hainer, V., Basdevant, A., Buchwald, H., Deitel, M., Finer, N., Greve, J. W., Horber, F., Mathus-Vliegen, E., Scopinaro, N., et al. (2008) · Obesity Facts · doi:10.1159/000113937 · Cited by 171
Chen, H. C., & Farese, R. V. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000151874.81059.ad · Cited by 171
Pharmacological targeting of the serotonergic system for the treatment of obesity
Garfield, A. S., & Heisler, L. K. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.164152 · Cited by 170
A simple estimate of mortality attributable to excess weight in the European Union
Banegas, J. R., López-García, E., Gutiérrez-Fisac, J. L., Guallar-Castillón, P., & Rodríguez-Artalejo, F. (2003) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601538 · Cited by 168
Lan, H., Vassileva, G., Corona, A., Liu, L., Baker, H., Golovko, A., Abbondanzo, S. J., Hu, W., Yang, S., Ning, Y., et al. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0453 · Cited by 167
N-acylethanolamines, anandamide and food intake
Hansen, H. S., & Diep, T. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.024 · Cited by 164
Morton, N. M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.024 · Cited by 163
Inhibition of 11ß-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target
Wamil, M., & Seckl, J. R. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.06.001 · Cited by 163
Gastrointestinal targets of appetite regulation in humans
Delzenne, N., Blundell, J., Brouns, F., Cunningham, K., De Graaf, K., Erkner, A., Lluch, A., Mars, M., Peters, H. P. F., & Westerterp‐Plantenga, M. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00707.x · Cited by 162
The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning?
Bermudez-Silva, F. J., Viveros, M. P., McPartland, J. M., & Rodriguez de Fonseca, F. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.03.012 · Cited by 160
Biochemical effects of SIRT1 activators
Baur, J. A. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.10.025 · Cited by 159
Schwarz, P., Lindström, J., Kissimova-Scarbeck, K., Szybinski, Z., Barengo, N., Peltonen, M., & Tuomilehto, J. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-992115 · Cited by 159
Elobeid, M. A., Padilla, M. A., McVie, T., Thomas, O., Brock, D. W., Musser, B., Lu, K., Coffey, C. S., Desmond, R. A., St-Onge, M.-P., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006624 · Cited by 158
Vancomycin Treatment of Infective Endocarditis Is Linked with Recently Acquired Obesity
Thuny, F., Richet, H., Casalta, J., Angelakis, E., Habib, G., & Raoult, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009074 · Cited by 158
Gut hormones: Implications for the treatment of obesity
Neary, M. T., & Batterham, R. L. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.005 · Cited by 158
Pharmacological management of appetite expression in obesity
Halford, J. C. G., Boyland, E. J., Blundell, J. E., Kirkham, T. C., & Harrold, J. A. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.19 · Cited by 157
Sexual Dimorphism in Body Fat Distribution and Risk for Cardiovascular Diseases
Nedungadi, T. P., & Clegg, D. J. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9101-1 · Cited by 156
Rimonabant for overweight or obesity
Curioni, C. C., & André, C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006162.pub2 · Cited by 154
Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer
Helmling, S., Maasch, C., Eulberg, D., Buchner, K., Schröder, W., Lange, C., Vonhoff, S., Wlotzka, B., Tschöp, M. H., Rosewicz, S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404175101 · Cited by 154
Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome
Ailhaud, G. P. (2006) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2005.12.012 · Cited by 154
Very‐Low‐Calorie Diets and Sustained Weight Loss
Saris, W. H. M. (2001) · Obesity Research · doi:10.1038/oby.2001.134 · Cited by 153
Keynote review: The adipocyte as a drug discovery target
Nawrocki, A. R., & Scherer, P. E. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03569-5 · Cited by 152
A Gut Feeling for Obesity: 7TM Sensors on Enteroendocrine Cells
Engelstoft, M. S., Egerod, K. L., Holst, B., & Schwartz, T. W. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.004 · Cited by 151
Semple, G., Fioravanti, B., Pereira, G. R., Calderon, I., Uy, J., Choi, K., Xiong, Y., Ren, A., Morgan, M. E., Davé, V., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8006867 · Cited by 144
CB1 antagonists for obesity—what lessons have we learned from rimonabant?
Marzo, V. D., & Després, J. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.197 · Cited by 141
End of the line for cannabinoid receptor 1 as an anti-obesity target?
Jones, D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2775 · Cited by 135
Carter, R., Moodie, M., Markwick, A., Magnus, A., Vos, T., Swinburn, B. A., & Haby, M. M. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-419 · Cited by 134
Moulin, A., Demange, L., Bergé, G., Gagne, D., Ryan, J. L., Mousseaux, D., Heitz, A., Perrissoud, D., Locatelli, V., Torsello, A., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0704550 · Cited by 133
Ahern, A. L., Olson, A. D., Aston, L. M., & Jebb, S. A. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-434 · Cited by 132
Self-citationTiwari, A., & Maiti, P. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.02.005 · Cited by 122
Sobetirome: a case history of bench-to-clinic drug discovery and development
Scanlan, T. S. (2008) · Heart Failure Reviews · doi:10.1007/s10741-008-9122-x · Cited by 121
Jordan, J., Greenway, F., Leiter, L., Li, Z., Jacobson, P., Murphy, K. E., Hill, J. O., Kler, L., & Aftring, R. P. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100272 · Cited by 120
Anti-obesity drugs and neural circuits of feeding
Adan, R. A. H., Vanderschuren, L. J. M. J., & ELAFLEUR, S. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.01.008 · Cited by 120
Villicev, C. M., Freitas, F. R. S., Aoki, M. S., Taffarel, C., Scanlan, T. S., Moriscot, A. S., Ribeiro, M. O., Bianco, A. C., & Gouveia, C. H. A. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07066 · Cited by 120
Cox, H. M., Tough, I. R., Woolston, A.-M., Zhang, L., Nguyen, A., Sainsbury, A., & Herzog, H. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.014 · Cited by 120
PYY3‐36 as an anti‐obesity drug target
Boggiano, M. M., Chandler-Laney, P. C., Oswald, K. D., Rodgers, R. J., Blundell, J. E., Ishii, Y., Beattie, A. H., Holch, P., Allison, D. B., Schindler, M., et al. (2005) · Obesity Reviews · doi:10.1111/j.1467-789x.2005.00218.x · Cited by 118
Exercise in the treatment of obesity
Jakicic, J. M. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(03)00075-6 · Cited by 116
Yoshimoto, R., Miyamoto, Y., Shimamura, K., Ishihara, A., Takahashi, K., Kotani, H., Chen, A. S., Chen, H. Y., MacNeil, D. J., Kanatani, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506104103 · Cited by 116
The obesity epidemic and its cardiovascular consequences
Behn, A., & Ur, E. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000231406.84554.96 · Cited by 115
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus
Norris, S. L., Zhang, X., Avenell, A., Gregg, E., Schmid, C. H., & Lau, J. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004096.pub2 · Cited by 113
Advice on low-fat diets for obesity
Summerbell, C., Cameron, C. M., & Glasziou, P. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003640.pub2 · Cited by 109
The Exercise Pill — Too Good to Be True?
Goodyear, L. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmcibr0806723 · Cited by 108
Nutritional counselling in general practice: a cost effective analysis.
Pritchard, D. A., Hyndman, J., & Taba, F. (1999) · Journal of Epidemiology & Community Health · doi:10.1136/jech.53.5.311 · Cited by 103
Behavioural interventions for preventing and treating obesity in adults
Sharma, M. (2007) · Obesity Reviews · doi:10.1111/j.1467-789x.2007.00351.x · Cited by 101
Searching for cost effectiveness thresholds in the NHS
Appleby, J., Devlin, N. J., Parkin, D. W., Buxton, M. J., & Chalkidou, K. (2009) · Health Policy · doi:10.1016/j.healthpol.2008.12.010 · Cited by 100
Getting away from glucose: fanning the flames of obesity-induced inflammation
Shoelson, S. E., & Goldfine, A. B. (2009) · Nature Medicine · doi:10.1038/nm0409-373 · Cited by 98
Kopelman, P. G., de Groot, H. G., Rissanen, A., Rössner, S., Toubro, S., Palmer, R., Hallam, R., Bryson, A. L., & Hickling, R. I. (2009) · Obesity · doi:10.1038/oby.2009.155 · Cited by 97
Arch, J. R. S. (2008) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-008-0271-1 · Cited by 96
Pioglitazone Increases the Proportion of Small Cells in Human Abdominal Subcutaneous Adipose Tissue
McLaughlin, T., Liu, T., Yee, G., Abbasi, F., Lamendola, C. A., Reaven, G. M., Tsao, P. S., Cushman, S. W., & Sherman, A. (2009) · Obesity · doi:10.1038/oby.2009.380 · Cited by 96
Bryzgalova, G., Effendic, S., Khan, A., Rehnmark, S., Barbounis, P., Boulet, J., Dong, G., Singh, R., Shapses, S., Malm, J., et al. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.06.010 · Cited by 94
Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators
Bemis, J. E., Vu, C. B., Xie, R. L., Nunes, J. J., Ng, P. Y., Disch, J. S., Milne, J. C., Carney, D. P., Lynch, A. V., Jin, L., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.11.106 · Cited by 93
Prevalence of Weight Cycling and its Relation to Health Indicators in Finland
Lahti‐Koski, M., Männistö, S., Pietinen, P., & Vartiainen, E. A. (2005) · Obesity Research · doi:10.1038/oby.2005.45 · Cited by 91
The Utility of Physical Activity in the Management of Global Cardiometabolic Risk
Janiszewski, P. M., & Ross, R. (2009) · Obesity · doi:10.1038/oby.2009.382 · Cited by 91
Guan, X.-M., Chen, H., Dobbelaar, P. H., Dong, Y., Fong, T. M., Gagen, K., Gorski, J. N., He, S., Howard, A. D., Jian, T., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.12.008 · Cited by 90
Stallmann-Jorgensen, I. S., Gutin, B., Hatfield-Laube, J. L., Humphries, M. C., Johnson, M. H., & Barbeau, P. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803587 · Cited by 90
Sirtuins: Novel targets for metabolic disease in drug development
Jiang, W. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.048 · Cited by 90
Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes
Gathercole, L., & Stewart, P. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.060 · Cited by 89
Current and Future Drug Targets in Weight Management
Witkamp, R. F. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0341-1 · Cited by 89
Research works printed but not linked: 2
- Goldney RD, Fisher LJ . Use of prescribed medications in a South Australian community sample. Med J Aust 2005; 183: 251–253. · doi:10.5694/j.1326-5377.2005.tb07030.x
- Olson AD, Jackson D, Seaman SR, Jebb SA, Mander AP . Missing data in weight loss randomised controlled trials. In Astrup A, (ed). 18th European Congress on Obesity (ECO 2011). Obesity Reviews: Instanbul, Turkey, 2011; p106.
Cited by
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
The Global Burden of Cancer 2013
Fitzmaurice, C., Dicker, D., Pain, A., Hamavid, H., Moradi-Lakeh, M., MacIntyre, M. F., Allen, C., Hansen, G., Woodbrook, R., Wolfe, C., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.0735 · Cited by 2,707
Metadata
- Authors
- Fuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., Jebb, S. A., & Caterson, I. D.
- Venue
- International Journal of Obesity
- Published
- 2012-08-28
- Volume
- 37
- Issue
- 6
- Pages
- 828-834
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W1987282451
- Cited by
- 2,117
- References
- 262
- FWCI
- 277.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.